Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Deferred Revenue (2020 - 2021)

BioAtla (BCAB) has disclosed Current Deferred Revenue for 2 consecutive years, with $482000.0 as the latest value for Q3 2021.

  • For Q3 2021, Current Deferred Revenue changed N/A year-over-year to $482000.0; the TTM value through Sep 2021 reached $482000.0, changed N/A, while the annual FY2020 figure was $387000.0, N/A changed from the prior year.
  • Current Deferred Revenue hit $482000.0 in Q3 2021 for BioAtla, down from $19.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $19.8 million in Q2 2021 and bottomed at $387000.0 in Q4 2020.